This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
FOXA1 antibody
catalog :
VMA00663KT
quantity :
2 Westerns
price :
108 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAbâ„¢ Monoclonal
EntityCategory :
Antibodies
ProductCode :
VMA00663KT
Description :
FOXA1 ANTIBODY WITH CONTROL LYSATE
Specificity :
FOXA1
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB
ApplicationTypes :
Western Blotting
Quantity :
2 Westerns
QuantityValue :
2
QuantityType :
Westerns
GOAccessions :
GO:0003690, GO:0003704, GO:0003705, GO:0005667, GO:0006338, GO:0009790, GO:0007389, GO:0008134, GO:0008301, GO:0008634, GO:0010552, GO:0010553, GO:0010843, GO:0016563, GO:0016566, GO:0019904, GO:0032355, GO:0033148, GO:0042593, GO:0045666, GO:0045931, GO:0048665, GO:0051091, GO:0060441, GO:0060487, GO:0060528, GO:0060738, GO:0060740, GO:0060741, GO:0060743
GOTerms :
activation of neuron differentiation, activation of progression through mitotic cell cycle, activation of transcription factor activity, chromatin modeling, chromatin modelling, chromatin remodelling, DNA binding, transcription promoter, down regulation of survival gene product activity, downregulation of survival gene product activity, down-regulation of survival gene product activity, dsDNA binding, embryogenesis, embryogenesis and morphogenesis, embryonal development, epithelial-mesenchymal signalling involved in prostate gland development, GO:0003710, GO:0009795, inhibition of survival gene product activity, lung branching morphogenesis, negative regulation of survival gene product activity, negative regulation of survival gene products, pattern biosynthesis, pattern formation, positive regulation of estrogen receptor signalling pathway, positive regulation of mitotic cell cycle progression, positive regulation of progression through mitotic cell cycle, prostate gland epithelial cell development, protein domain-specific binding, pulmonary epithelial cell differentiation, response to E2 stimulus, stimulation of neuron differentiation, stimulation of progression through mitotic cell cycle, stimulation of transcription factor activity, TF binding, transcription activating factor, transcriptional activator activity, up regulation of neuron differentiation, up regulation of progression through mitotic cell cycle, up regulation of transcription factor activity, upregulation of neuron differentiation, up-regulation of neuron differentiation, upregulation of progression through mitotic cell cycle, up-regulation of progression through mitotic cell cycle, upregulation of transcription factor activity, up-regulation of transcription factor activity
UniprotAccessions :
P55317
Gene :
FOXA1
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3169
EntityFormats :
Purified
UNSPSC :
12352203
ProductForm :
Purified IgG - liquid
PriceDKK :
804
PrimarySecondary :
Primary
PriceGBP :
83
PriceEUR :
108
PriceUSD :
108 USD
PriceCHF :
126
PriceSEK :
1077
PriceNOK :
1070
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.